Find the latest Earnings Report Date for Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) at Nasdaq.com. Company Name: Aurinia Pharmaceuticals Inc, Stock Symbol: AUPH, Industry: Biotechs, Total Posts: 12424, Last Post: 3/8/2021 10:17:21 AM stocknique Last visit ... With a 1.732B MARKET CAP and a Net Income (FY) of -126.725M, the stock seems overvalued and needs a correction. Aurinia Pharmaceuticals Inc. NASDAQ Updated Mar 6, 2021 12:59 AM AUPH 13.09 0.32 (2.39%). This price target is based on 8 analysts offering 12 month price targets for Aurinia Pharmaceuticals in the last 3 months. Post-Market 0.11 (0.84%) The companyÂs lead drug candidate is Voclosporin, a calcineurin inhibitor, which is in Phase IIb clinical trial for the treatment of lupus nephritis. AUPH's Return on Equity is forecast to be high in 3 years (78.15%); analysts are confident in the firm's ability to efficiently generate return on equity, AUPH is forecast to generate higher Return on Assets (68.73%) than the US Biotechnology industry average (21.96%), AUPH's revenue is forecast to grow at an exceptional rate of 103.19% per year, AUPH's revenues are forecast to grow faster (103.19% per year) than the US Biotechnology industry average (62.44%), AUPH's revenues are forecast to grow faster (103.19% per year) than the US market average (24.98%), On average, Wall Street analysts predict that. If the lower trend floor at $12.74 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Over the last 30 days, this security got 1 buy, 0 sell and 0 hold ratings. Users should not base their investment decision upon "StockInvest.us". Get the latest Aurinia Pharmaceuticals Inc AUPH detailed stock quotes, stock data, Real-Time ECN, charts, stats ⦠The ⦠View IEXâs Terms of Use. We use big data and artificial intelligence to forecast the stock price of Aurinia Pharmaceuticals Inc - AUPH. The Aurinia Pharmaceuticals stock forecast is 29.37824 USD for 2022 February 19, Saturday; and 105.966 USD for 2026 ⦠Terms of Use and Privacy Policy. AUPH Stock Trend. Aurinia Pharmaceuticals (AUPH) stock price prediction is 29.37824 USD. What is AUPH's revenue growth forecast for 2021-2023? Based on our forecasts, a long-term increase is expected, the "AUPH" stock price prognosis for 2026-02-27 is 39.972 USD. We are all together in this COVID-19 pandemic. On average, they expect Aurinia Pharmaceuticals' share price to reach $27.71 in the next twelve months. Their average twelve-month price target is $27.71, predicting that the stock has a possible upside of 92.73%. Your current $100 investment may be up to $305.36 in 2026. Their forecasts range from $20.00 to $35.00. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . View real-time stock prices and stock quotes for a full financial overview. Aurinia Pharmaceuticals Inc (AUPH:NMQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. A rank of 47 means that 53% of stocks ⦠By using the site you agree and are held Real-time data provided for free by IEX. On average, 6 Wall Street analysts forecast AUPH's earnings for 2022 to be $-26,971,785, with the lowest AUPH earnings forecast at $-88,515,000, and the highest AUPH earnings forecast at ⦠Aurinia Pharmaceuticals Inc. (AUPH) estimates and forecasts WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. WARNING: Trend forecast is still in the development phase and should be used with caution. Aurinia Pharmaceuticals ⦠It has a collaboration agreement with Paladin Labs Inc. to maintain the patent portfolio for Voclosporin in Canada, South Africa, and Israe... Read more. and has now fallen 4 days in a row. 8 Wall Street analysts have issued 1-year price targets for Aurinia Pharmaceuticals' shares. This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.This signal is rare and, in most cases, gives substantial returns. The indicators signal: Sell on 1h timeframe Sell on 7h timeframe Sell on daily... 1. In 2023, AUPH is forecast to generate $55,117,658,250 in revenue, with the lowest revenue forecast at $51,200,869,500 and the highest revenue forecast at $58,145,503,500. Some cases might produce unexpected results such as negative prices at the end of the trend. Given the current short-term trend, the stock is expected to rise 5.62% during the next 3 months and, with a 90% probability hold a price between $13.45 and $20.33 at the end of this 3-month period. All users should speak with their financial advisor before buying or selling any securities. AUPH forecasts Videos only. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 8 Wall Street analysts have issued ratings and price targets for Aurinia Pharmaceuticals in the last 12 months. Please read the full disclaimer here. The Aurinia Pharmaceuticals Inc stock price fell by -6.75% on the last day (Thursday, 4th Mar 2021) from $14.38 to $13.41. Aurinia Pharmaceuticals Inc., a clinical stage pharmaceutical company, engages in the development of a therapeutic drug to treat autoimmune diseases in Canada. What this means: InvestorsObserver gives Aurinia Pharm Ord (AUPH) an overall rank of 47, which is below average. featured in The Global Fintech Index 2020 as the top Fintech company of the country. The high price target for AUPH is $35.00 and the low price target for AUPH ⦠Given the current short-term trend, the stock is expected to rise 7.27% ⦠From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day! It follows that stockâs price at last check today has to jump +181.12% in reaching the projected high whereas dropping to the targeted low would mean a loss of 43.78% for stockâs latest value. AUPH -- USA Stock USD 14.00 0.58 3.98% Aurinia Pharm Ord stock price prediction is an act of determining the future value of Aurinia Pharm shares using few different conventional methods such ⦠Top authors: AUPH. liable for your own investment decisions and agree to View Aurinia Pharmaceuticals Inc AUPH investment & stock information. With a 5-year investment, the revenue is expected to be around +205.36%. "StockInvest.us" is a research service that provides financial data and technical analysis of publicly traded stocks. What is AUPH's Earnings Per Share (EPS) forecast for 2021-2023? A high-level overview of Aurinia Pharmaceuticals Inc. (AUPH) stock. Our stock price predictions cover a period of 3 months. AUPH ⦠During the day the stock fluctuated 9.17% ⦠This suggests a possible upside of 98.0% from the stock's ⦠Based on 6 analysts offering 12 month price targets for Aurinia Pharmaceuticals in the last 3 months. We cover the US equity market. Aurinia Pharmaceuticals Inc. (AUPH) latest earnings report: revenue, EPS, surprise, history, news and analysis. The average price target is $27.71, with a high forecast of $35.00 and a low forecast of ⦠Is Aurinia Pharmaceuticals Stock a good buy in 2021, according to Wall Street analysts? Your losses are our losses too. AUPH | Complete Aurinia Pharmaceuticals Inc. stock news by MarketWatch. Aurinia Pharmaceuticals Inc Stock Price Forecast, "AUPH" Predictons for2021 Based on analysts offering 12 month price targets for AUPH in the last 3 months. etom21 Last visit Follow Following Unfollow. This is why we are offering FREE 14 days TRIAL SUBSCRIPTIONS with no further commitments. Aurinia Pharm Ord is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Find real-time AUPH - Aurinia Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. The average price target is $29.00 with a high forecast of $35.00 and a low forecast of $23.00. What is AUPH's forecast return on equity (ROE) for 2021-2024? The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. What is AUPH's forecast return on assets (ROA) for 2021-2024? 0. Find the latest Aurinia Pharmaceuticals Inc (AUPH) stock quote, history, news and other vital information to help you with your stock trading and investing. What is AUPH's earnings growth forecast for 2021-2023? Get Our PREMIUM Forecast ⦠In 2023, AUPH is forecast to generate $135,718,785 in earnings, with the lowest earnings forecast at $92,308,500 and the highest earnings forecast at $166,914,000. Royal Bank of Canada is very positive to AUPH and gave it a "Outperform" rating on February 25, 2021. The price target was set to $28.00 â $26.00. Aurinia Pharmaceuticals Inc Stock Forecast Over the next 52 weeks, Aurinia Pharmaceuticals Inc has on average historically risen by 39.4 % based on the past 11 years of stock performance.